1. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma;Child;N Engl J Med,2003
2. High-dose therapy (HDT) and autologous blood stem cell (ABSC) transplantation versus conventional treatment in multiple myeloma (MM): results of a randomized trial in 190 patients 55 to 65 years of age;Fermand;Blood,1999
3. Comparable survival in multiple myeloma (MM) with high-dose therapy (HDT) following mel 140 mg/m2 + TBI 12 by autotransplants versus standard dose therapy with VBMCP and no benefit from interferon (IFN) maintenance: results of Intergroup trial S9321;Barlogie;Blood,2003
4. The treatment of multiple myeloma;Alexanian;N Engl J Med,1994
5. The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycine-based chemotherapy for multiple myeloma;Baz;Mayo Clinci Proc,2005